Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccination coverage in Germany].

S Reiter1

  • 1Robert Koch-Institut, Berlin. ReiterS@rki.de

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of the Radiative Decay D_{s0}^{*}(2317)^{+}→D_{s}^{*+}γ.

Physical review letters·2026
Same author

First Search for B→X_{s}νν[over ¯] Decays.

Physical review letters·2026
Same author

Search for Feebly Interacting Particles in B Decays with Missing Energy at Belle.

Physical review letters·2026
Same author

Search for B^{0}→K^{*0}τ^{+}τ^{-} Decays at the Belle II Experiment.

Physical review letters·2025
Same author

Search for a Dark Higgs Boson Produced in Association with Inelastic Dark Matter at the Belle II Experiment.

Physical review letters·2025
Same author

Structured clinical evaluation for rapid identification of temporomandibular joint closed lock.

International journal of oral and maxillofacial surgery·2025

Accurate vaccination coverage and seroprevalence data are crucial for improving vaccine acceptance and closing existing gaps in Germany. Enhanced surveillance is needed to ensure complete vaccination status in children, adolescents, and adults.

Area of Science:

  • Public Health
  • Epidemiology
  • Immunization

Background:

  • Up-to-date vaccination coverage and seroprevalence data are essential for public health strategies.
  • Current data sources in Germany for vaccination status are limited and often not age-appropriate.
  • Existing data suggest significant vaccination coverage gaps, particularly for specific vaccines, in both children and adults.

Purpose of the Study:

  • To highlight the need for improved surveillance of vaccination coverage and seroprevalence in Germany.
  • To emphasize the importance of accurate data for increasing vaccination acceptance and coverage.
  • To address the limitations of current data sources for assessing vaccination status across all age groups.

Main Methods:

  • The study reviews existing data sources for vaccination coverage and seroprevalence in Germany.

Related Experiment Videos

  • It identifies limitations in current data, including age-appropriateness and estimation-based assessments.
  • The abstract implies a need for enhanced surveillance systems.

    • Main Results:

    • Vaccination coverage and seroprevalence data in Germany are currently limited.
    • Existing data sources provide only estimates or are not suitable for all age groups.
    • Important vaccination coverage gaps exist for certain vaccines, and adult vaccination status is often incomplete.

    Conclusions:

    • Improved surveillance of vaccination coverage and seroprevalence is critical for public health in Germany.
    • Enhanced data collection can contribute to closing identified vaccination gaps.
    • Ensuring complete vaccination status across all age groups requires better data infrastructure.